Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction.

ABSTRACT: The aim of this retrospective study was to provide real-world data on lipid-lowering therapy (LLT) implementation and low-density lipoprotein cholesterol (LDL-C) target achievement in an ST-segment elevation myocardial infarction (STEMI) population, with a focus on very-high-risk patients according to European guidelines criteria.

Methods

Included were all STEMI patients with available LDL-C and total cholesterol treated at a large tertiary center in Salzburg, Austria, 2018-2020 (n = 910), with stratification into very-high-risk cohorts. Analysis was descriptive, with variables reported as number, percentages, median, and interquartile range.

Results

Among patients with prior LLT use, statin monotherapy predominated, 5.3% were using high-intensity statins, 1.2% were us

SUBMITTER: Kopp K 

PROVIDER: S-EPMC10488884 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature